Consolidated PAT ₹892 Cr up 15% but margins compress; underlying flat as a one-off flatters
PAT +15.4% YoY · revenue +79.2% · margins compressing · miss vs street
₹7,931.79 Cr
+79.2% YoY
₹891.87 Cr
+15.4% YoY
11.01%
-5.8pp YoY
₹29.56
Consolidated revenue from operations of ₹7,931.79 Cr rose 79.2% YoY off a ₹4,425.83 Cr year-ago base but slipped 6.5% sequentially from Q4's ₹8,480.25 Cr. Net profit of ₹891.87 Cr (₹850.22 Cr to owners) grew a much slower 15.4% YoY and fell 20.8% QoQ, taking EPS to ₹29.56 from ₹36.91 last quarter. The gap between an ~80% topline and a 15% bottom line is the quarter's story — profit is not scaling with revenue.
Q1 FY-2027 vs prior quarters
Both lines are flattered by a one-off: a ₹349.28 Cr IEEPA reciprocal-duty refund (net of amounts due to customers), recognised as other operating revenue after the US Supreme Court struck down the reciprocal duties, with a ₹282.30 Cr equivalent in the standalone entity. Stripping the ~₹257 Cr post-tax benefit, underlying PAT actually declined ~18% YoY — so the reported +15% is closer to ~-18% adjusted. Net margin compressed to 11.0% (16.8% a year ago, 13.0% last quarter) and operating EBITDA margin to ~18% (22.5% YoY); ex the refund, EBITDA margin is nearer 14%. The squeeze sits in gross margin and realisation as module capacity scales ahead of pricing — the oversupply risk the bears flagged.
The stock went into the print at ₹2,736.2, down 7.2% over the past month of trading.
Management guides for FY27 operating EBITDA of INR 7,000 to INR 7,700 crores, driven by capacity scaling and the execution of its ambitious 'Waaree 2.0' strategy. This involves significant capex in vertical integration (cells, wafers, glass) and diversification into new energy segments like BESS, inverters, and electro
On the Street's own litmus from our pre-result preview — bulls needed EBITDA margins recovering to 21-23% to validate the thesis, a stall below 19% confirming cyclical-peak risk — Q1's ~18% (14% adjusted) lands on the bear side, and Simply Wall St flags an ~10% EPS miss versus consensus; UBS's July 14 downgrade (margin compression, capex execution risk) reads as vindicated on this print. Management's Q4 guidance is unbroken but back-ended: FY27 EBITDA of ₹7,000-7,700 Cr with margins recovering to 19-20% in H2 as 10 GW of new cell capacity comes online. Q1 EBITDA of ~₹1,440 Cr is only ~19-21% of the full-year floor, so FY27 is now entirely an H2 story; management gives no formal quarterly guidance and issued no separate press release with this result.
W1
Margin recovery: management guides EBITDA margin to 19-20% in H2 FY27 as 10 GW cell capacity comes online; Q1 was ~18% (14% ex refund) — verify the H2 uplift
W2
FY27 EBITDA guidance ₹7,000-7,700 Cr; Q1 delivered ~₹1,440 Cr (~19-21% of the floor) — track the back-ended ramp
W3
BESS contribution (facility live July, immaterial to Q1) and CBP/AD-CVD investigation outcome
Informational and educational content only. Not investment advice.